Cresco Labs (CRLBF) EBT (2020 - 2026)

Cresco Labs has reported EBT for 7 years, with the latest figure at -$2.8 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 204.36% year-over-year to -$2.8 million; the trailing twelve-month figure through Mar 2026 stood at -$97.3 million (down 254.04% YoY), and the FY2025 full-year result was -$95.4 million, down 798.85% from the prior year.
• EBT for Q1 2026 stood at -$2.8 million, up from -$87.1 million in the prior quarter.
• The five-year high for EBT was $15.9 million in Q1 2024, with the low at -$156.9 million in Q4 2022.
• Historically, EBT has averaged -$22.5 million across 5 years, with a median of -$918000.0 in 2025.
• Annual changes were most pronounced in 2024 — EBT soared 244.94% — and 2025, when it tumbled 2952.54%.
• Cresco Labs' EBT stood at -$156.9 million in 2022, then soared by 108.17% to $12.8 million in 2023, then tumbled by 76.17% to $3.1 million in 2024, then plunged by 2952.54% to -$87.1 million in 2025, then soared by 96.79% to -$2.8 million in 2026.
• The last three EBT figures came in at -$2.8 million (Q1 2026), -$87.1 million (Q4 2025), and -$10.1 million (Q3 2025), per Business Quant data.